BioCentury
ARTICLE | Company News

GTC Biotherapeutics, AgResearch, Dong-A Pharmaceutical deal

March 2, 2009 8:00 AM UTC

GTC and AgResearch will develop transgenic goats to produce two biosimilar mAbs of undisclosed marketed drugs. GTC said the deal is part of its long term biosimilar strategy and will enable earlier sales of the products in Europe. A majority of development costs will be funded by a grant from the New Zealand government. AgResearch is eligible for royalties on the biosimilars. Further terms were not disclosed. ...